AXA Framlington Health R Acc

Category Sector Equity Healthcare


star-filledstar-filledstar-filledstar-filled
Last buy/sell price

3,258.00p

arrow-up36.00p (+1.12%)

Fund Code

0350642

GB0003506424

Prices updated as at 07 May 2024
|
Prices in GBX

Investment objective
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.

Portfolio as of 31/03/2024

Asset allocation

Show long & short position

Geographical breakdown

Continent or country allocation (%)

Market classification (%)

Stock style

Large core

35.24%

% Weight
Value
Core
Growth
Large

5

35

34

Medium

2

5

14

Small

0

2

3

Valuation

AXA Framlington Health R Acc
Sector Equity Healthcare

23.95

23.95
21.44

2.48

2.48
1.94

5.40

5.40
4.72

20.93

20.93
18.84

Growth rate

AXA Framlington Health R Acc
Sector Equity Healthcare

11.84%

11.84%
11.38%

1.14%

1.14%
1.32%

42.81%

42.81%
-2.36%

Top 10 holdings

1
Eli Lilly and Co
Sector
-
Country
United States
% of assets
9.06256
2
Novo Nordisk A/S Class B
Sector
-
Country
Denmark
% of assets
7.57514
3
UnitedHealth Group Inc
Sector
-
Country
United States
% of assets
6.94487
4
Merck & Co Inc
Sector
-
Country
United States
% of assets
5.8823
5
Thermo Fisher Scientific Inc
Sector
-
Country
United States
% of assets
4.59412
6
AstraZeneca PLC
Sector
-
Country
United Kingdom
% of assets
3.88471
7
Abbott Laboratories
Sector
-
Country
United States
% of assets
3.22877
8
Sanofi SA
Sector
-
Country
France
% of assets
2.9003
9
Boston Scientific Corp
Sector
-
Country
United States
% of assets
2.77691
10
McKesson Corp
Sector
-
Country
United States
% of assets
2.74081
Assets in top 10 holdings %

49.59%

Total no. of equity holdings

45.00

Total no. of bond holdings

-

Stock sectors

AXA Framlington Health R Acc
Sector Equity Healthcare

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

0.57%

Comm services

-
-

Energy

-
-

Industrials

0.57%
-

Technology

-
-

99.43%

Con defensive

-
-

Healthcare

99.43%
-

Utilities

-
-

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.